MT Newswires
Amgen Acquires Dark Blue Therapeutics for $840 Million
📈
AI Sentiment
Highly Positive
8/10
Amgen Inc. News
Latest updates and market news for AMGN
12 news
Jan 1 - Jan 7, 2026
Page 1
PR Newswire
Dark Blue Therapeutics acquired by Amgen for up to $840 million
📈
AI Sentiment
Highly Positive
10/10
PR Newswire
AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
📈
AI Sentiment
Highly Positive
9/10
Clinical Trials Arena
Zenas’ stock drops 51% despite lead asset’s Phase III rare disease win
📉
AI Sentiment
Negative
3/10
Zacks
Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors
➖
AI Sentiment
Neutral
4/10
Investor's Business Daily
Stock Market Today: Dow Surges As Maduro Makes This Plea; This AI Stock Clears An Entry (Live Coverage)
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
Zenas BioPharma, A Top 1% Stock, Quadrupled In 2025. Why It Just Collapsed.
📉
AI Sentiment
Negative
3/10
Zacks
Beat the Market the Zacks Way: LATAM, General Motors, Amgen in Focus
📉
AI Sentiment
Negative
3/10
Simply Wall St.
Taking Another Look at Amgen (AMGN)’s Valuation After Its Recent Share Price Pullback
📊
AI Sentiment
Positive
7/10
Zacks
Axsome (AXSM) Stock Jumps 22.8%: Will It Continue to Soar?
📈
AI Sentiment
Highly Positive
8/10
Share this news page